These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 30481750)
1. iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii. Yang N; Liu Y; He P; Ke R; Zhao Y; Feng Y; Jing R; Ma S; Liu C; Geng Y; Wu X; Wei Y Cell Physiol Biochem; 2018; 51(3):1327-1339. PubMed ID: 30481750 [TBL] [Abstract][Full Text] [Related]
2. Novel tigecycline resistance mechanisms in Hua X; He J; Wang J; Zhang L; Zhang L; Xu Q; Shi K; Leptihn S; Shi Y; Fu X; Zhu P; Higgins PG; Yu Y Emerg Microbes Infect; 2021 Dec; 10(1):1404-1417. PubMed ID: 34170209 [No Abstract] [Full Text] [Related]
3. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii. Jo J; Ko KS Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993 [TBL] [Abstract][Full Text] [Related]
4. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism. Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072 [TBL] [Abstract][Full Text] [Related]
5. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients. Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
7. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance. Lin MF; Lin YY; Tu CC; Lan CY J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688 [TBL] [Abstract][Full Text] [Related]
8. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii. Idelevich EA; Freeborn DA; Seifert H; Becker K Diagn Microbiol Infect Dis; 2018 Aug; 91(4):360-362. PubMed ID: 29778562 [TBL] [Abstract][Full Text] [Related]
9. [Resistance of Qu JY; Ü XJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):248-252. PubMed ID: 28612536 [TBL] [Abstract][Full Text] [Related]
10. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran. Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349 [TBL] [Abstract][Full Text] [Related]
11. COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN Bedenić B; Cavrić G; Vranić-Ladavac M; Barišić N; Karčić N; Tot T; Presečki-Stanko A; Lukić-Grlić A; Frančula-Zaninović S; Sreter KB Acta Clin Croat; 2018 Dec; 57(4):618-623. PubMed ID: 31168197 [TBL] [Abstract][Full Text] [Related]
12. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates. Li H; Wang X; Zhang Y; Zhao C; Chen H; Jiang S; Zhang F; Wang H Future Microbiol; 2015; 10(3):337-46. PubMed ID: 25812457 [TBL] [Abstract][Full Text] [Related]
13. Insights into the Periplasmic Proteins of Scribano D; Marzano V; Levi Mortera S; Sarshar M; Vernocchi P; Zagaglia C; Putignani L; Palamara AT; Ambrosi C Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337077 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528 [TBL] [Abstract][Full Text] [Related]
15. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ruzin A; Keeney D; Bradford PA J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424 [TBL] [Abstract][Full Text] [Related]
16. Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline. Hua X; Zhou H; Jiang Y; Feng Y; Chen Q; Ruan Z; Yu Y J Bacteriol; 2012 Dec; 194(24):6979-80. PubMed ID: 23209232 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. Tiengrim S; Tribuddharat C; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251 [TBL] [Abstract][Full Text] [Related]
18. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
19. The Mechanism of Tigecycline Resistance in Liu C; Liu J; Lu Q; Wang P; Zou Q Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339095 [TBL] [Abstract][Full Text] [Related]
20. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia. Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]